Effects of Genetic Variations in the Response to Brazil Nut Supplementation (SUBRANUT)

May 30, 2018 updated by: Janaina Donadio, University of Sao Paulo

Genetic Variants in Selenoprotein Genes and Gender Influence Biomarkers of Se Status in Response to Brazil Nut Supplementation in Healthy Brazilians

This study investigates the effect of genetic variations after supplementation with Brazil nuts in healthy Brazilians. Briefly, all the participants will consume one nut a day for 2 months and will stop the intake for more 2 months. Five blood sampling collection will be performed in one month interval, starting at baseline and ending at 2 months without intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Brazil nuts are the richest source of selenium in nature, a micronutrient that has essential functions in human physiology.

Selenium status can be measured by the quantification of biomarkers in the blood. Previous studies have shown that genetic polymorphisms can affect Se status and modulate risk for chronic diseases. In this study, five biomarkers will be quantified in the blood, before and after supplementation with Brazil nuts. The genetic variants will be used to stratify the biomarkers and multivariate linear regressions will be used to explore the influence of the polymorphisms on concentrations of the biomarkers .

Study Type

Interventional

Enrollment (Actual)

129

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 20 and 60 years; not taking vitamin and minerals supplements, not taking antiinflammatory, not having chronic diseases

Exclusion Criteria:

  • athletes, excessive alcohol consumption, being obese, having cancer, cardiovascular disease, diabetes and hypo or hyperthyroidism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brazil Nut supplementation
Consumption of one Brazil nut a day for 2 months followed by 2 months without intervention
one nut a day for 2 months, no intervention for 2 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in Plasma Se concentrations
Time Frame: 4 weeks
measured by ICP-MS (ug/L)
4 weeks
change in Plasma Glutathione Peroxidase 3 activity
Time Frame: 4 weeks
measured by kinetic assay in a spectrometer (U/L)
4 weeks
change in Plasma Selenoprotein P concentrations
Time Frame: 4 weeks
measured by ELISA (mg/dL)
4 weeks
change in Erythrocyte Se concentrations
Time Frame: 4 weeks
measured by ICP-MS (ug/L)
4 weeks
change in Erythrocyte Glutathione Peroxidase 1 activity
Time Frame: 4 weeks
measured by kinetic assay in an automatic spectrometer (U/gHb)
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in total cholesterol concentration in serum
Time Frame: 4 weeks
measured in an automatic spectrometer (mg/dL)
4 weeks
change in tryglicerides concentration in serum
Time Frame: 4 weeks
measured in an automatic spectrometer (mg/dL)
4 weeks
change in HDL concentration in serum
Time Frame: 4 weeks
measured in an automatic spectrometer (mg/dL)
4 weeks
change in LDL concentration in serum
Time Frame: 4 weeks
measured in an automatic spectrometer (mg/dL)
4 weeks
change in protein-c reactive concentration in serum
Time Frame: 4 weeks
measured in an automatic spectrometer (mg/dL)
4 weeks
change in Plasma MDA concentrations (malondialdehyde)
Time Frame: 4 weeks
measured in an automatic spectrometer (mg/dL)
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Silvia MF Cozzolino, PhD, University of São Paulo

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2013

Primary Completion (Actual)

August 15, 2014

Study Completion (Actual)

April 19, 2016

Study Registration Dates

First Submitted

March 27, 2017

First Submitted That Met QC Criteria

April 6, 2017

First Posted (Actual)

April 12, 2017

Study Record Updates

Last Update Posted (Actual)

June 1, 2018

Last Update Submitted That Met QC Criteria

May 30, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • USPBR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary Supplements

Clinical Trials on Brazil nut

Subscribe